Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377130 · ClinicalTrials.gov registry record · NA
Stress Management Therapy in Patients Receiving Chemotherapy for Cancer
A NA study, sponsored by University of South Florida.
- Completed
- Registry status
- NA
- Development phase
- 442
- Enrollment target
NCT00377130: Completed NA study, sponsored by University of South Florida.
NCT00377130 is a NA study that has completed, run by University of South Florida. The registered enrollment target is 442 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00377130, a NA study, has completed, sponsored by University of South Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 442 participants
- Enrollment target
Study Summary
RATIONALE: A stress-management program may improve quality of life and reduce anxiety and depression in patients receiving chemotherapy for cancer. PURPOSE: This randomized clinical trial is studying how well stress management therapy works in patients receiving chemotherapy for cancer.
Primary Outcome
Assessed at baseline (before first chemotherapy cycle) and just before the start of the second, third and fourth chemotherapy cycles.
Interventions
- OTHER Self Administered Stress Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2006-12 |
| Est. Completion | 2010-05 |
| Phase | NA |
What the finished NCT00377130 record still lists
NCT00377130 is an interventional study that assigns participants to a tested intervention. The registered 442 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Self Administered Stress Management is the first listed.
NCT00377130 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00377130 about?
NCT00377130 is a clinical study titled "Stress Management Therapy in Patients Receiving Chemotherapy for Cancer". RATIONALE: A stress-management program may improve quality of life and reduce anxiety and depression in patients receiving chemotherapy for cancer. PURPOSE: This randomized clinical trial is studying how well stress management therapy works in patients receiving chemotherapy for cancer.
What is the current status of trial NCT00377130?
This trial is currently completed. It is a NA study. The enrollment target is 442 participants. The study started on 2006-12. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00377130?
The interventions under investigation include: Self Administered Stress Management (OTHER).
Who is sponsoring clinical trial NCT00377130?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00377130's enrollment target sits among peer trials
442 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
- NCT06659029 · 442 participants
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia